A citation-based method for searching scientific literature

Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
Times Cited: 1092







List of co-cited articles
759 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma.
Xiaoli Liu, Guojun Wu, Yuan Shan, Christian Hartmann, Andreas von Deimling, Mingzhao Xing. Cell Cycle 2013
95
4

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
553
4


Telomerase activity in human germline and embryonic tissues and cells.
W E Wright, M A Piatyszek, W E Rainey, W Byrd, J W Shay. Dev Genet 1996
947
4

Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature.
Nils Johan Fredriksson, Kerryn Elliott, Stefan Filges, Jimmy Van den Eynden, Anders Ståhlberg, Erik Larsson. PLoS Genet 2017
31
12

ETS transcription factors induce a unique UV damage signature that drives recurrent mutagenesis in melanoma.
Peng Mao, Alexander J Brown, Shingo Esaki, Svetlana Lockwood, Gregory M K Poon, Michael J Smerdon, Steven A Roberts, John J Wyrick. Nat Commun 2018
38
10

LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
Lucas Lochovsky, Jing Zhang, Yao Fu, Ekta Khurana, Mark Gerstein. Nucleic Acids Res 2015
38
10

Recurrent and functional regulatory mutations in breast cancer.
Esther Rheinbay, Prasanna Parasuraman, Jonna Grimsby, Grace Tiao, Jesse M Engreitz, Jaegil Kim, Michael S Lawrence, Amaro Taylor-Weiner, Sergio Rodriguez-Cuevas, Mara Rosenberg,[...]. Nature 2017
146
4

Non-coding recurrent mutations in chronic lymphocytic leukaemia.
Xose S Puente, Silvia Beà, Rafael Valdés-Mas, Neus Villamor, Jesús Gutiérrez-Abril, José I Martín-Subero, Marta Munar, Carlota Rubio-Pérez, Pedro Jares, Marta Aymerich,[...]. Nature 2015
468
4

Integrative annotation of variants from 1092 humans: application to cancer genomics.
Ekta Khurana, Yao Fu, Vincenza Colonna, Xinmeng Jasmine Mu, Hyun Min Kang, Tuuli Lappalainen, Andrea Sboner, Lucas Lochovsky, Jieming Chen, Arif Harmanci,[...]. Science 2013
237
4

Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes.
Dilmi Perera, Rebecca C Poulos, Anushi Shah, Dominik Beck, John E Pimanda, Jason W H Wong. Nature 2016
109
4

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J Brat, Roel G W Verhaak, Kenneth D Aldape, W K Alfred Yung, Sofie R Salama, Lee A D Cooper, Esther Rheinbay, C Ryan Miller, Mark Vitucci, Olena Morozova,[...]. N Engl J Med 2015
4

IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
4


Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
Vera B Kaiser, Martin S Taylor, Colin A Semple. PLoS Genet 2016
36
11

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
117
4

The chromatin accessibility landscape of primary human cancers.
M Ryan Corces, Jeffrey M Granja, Shadi Shams, Bryan H Louie, Jose A Seoane, Wanding Zhou, Tiago C Silva, Clarice Groeneveld, Christopher K Wong, Seung Woo Cho,[...]. Science 2018
216
4

Role of non-coding sequence variants in cancer.
Ekta Khurana, Yao Fu, Dimple Chakravarty, Francesca Demichelis, Mark A Rubin, Mark Gerstein. Nat Rev Genet 2016
236
4

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Kristian Cibulskis, Michael S Lawrence, Scott L Carter, Andrey Sivachenko, David Jaffe, Carrie Sougnez, Stacey Gabriel, Matthew Meyerson, Eric S Lander, Gad Getz. Nat Biotechnol 2013
4

Distinct sets of genetic alterations in melanoma.
John A Curtin, Jane Fridlyand, Toshiro Kageshita, Hetal N Patel, Klaus J Busam, Heinz Kutzner, Kwang-Hyun Cho, Setsuya Aiba, Eva-Bettina Bröcker, Philip E LeBoit,[...]. N Engl J Med 2005
4

The hallmarks of cancer.
D Hanahan, R A Weinberg. Cell 2000
4

TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation.
Helena Pópulo, Paula Boaventura, João Vinagre, Rui Batista, Adélia Mendes, Regina Caldas, Joana Pardal, Filomena Azevedo, Mrinalini Honavar, Isabel Guimarães,[...]. J Invest Dermatol 2014
76
5

Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.
Barbara Heidenreich, Eduardo Nagore, P Sivaramakrishna Rachakonda, Zaida Garcia-Casado, Celia Requena, Victor Traves, Jürgen Becker, Nadem Soufir, Kari Hemminki, Rajiv Kumar. Nat Commun 2014
114
4

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
442
4

Telomeres in cancer: tumour suppression and genome instability.
John Maciejowski, Titia de Lange. Nat Rev Mol Cell Biol 2017
249
4

Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma.
Brittani Seynnaeve, Seungjae Lee, Sumit Borah, Yongseok Park, Alberto Pappo, John M Kirkwood, Armita Bahrami. Sci Rep 2017
29
13

Extension of life-span by introduction of telomerase into normal human cells.
A G Bodnar, M Ouellette, M Frolkis, S E Holt, C P Chiu, G B Morin, C B Harley, J W Shay, S Lichtsteiner, W E Wright. Science 1998
4


Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Helen Zhu, Liis Uusküla-Reimand, Keren Isaev, Lina Wadi, Azad Alizada, Shimin Shuai, Vincent Huang, Dike Aduluso-Nwaobasi, Marta Paczkowska, Diala Abd-Rabbo,[...]. Mol Cell 2020
13
30

Activation of proto-oncogenes by disruption of chromosome neighborhoods.
Denes Hnisz, Abraham S Weintraub, Daniel S Day, Anne-Laure Valton, Rasmus O Bak, Charles H Li, Johanna Goldmann, Bryan R Lajoie, Zi Peng Fan, Alla A Sigova,[...]. Science 2016
438
4

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Michael Weller, Martin van den Bent, Jörg C Tonn, Roger Stupp, Matthias Preusser, Elizabeth Cohen-Jonathan-Moyal, Roger Henriksson, Emilie Le Rhun, Carmen Balana, Olivier Chinot,[...]. Lancet Oncol 2017
431
4

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang,[...]. J Clin Endocrinol Metab 2014
178
4

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
75
5

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
4

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.
R K Moyzis, J M Buckingham, L S Cram, M Dani, L L Deaven, M D Jones, J Meyne, R L Ratliff, J R Wu. Proc Natl Acad Sci U S A 1988
4

Direct activation of TERT transcription by c-MYC.
K J Wu, C Grandori, M Amacker, N Simon-Vermot, A Polack, J Lingner, R Dalla-Favera. Nat Genet 1999
698
4


COSMIC: the Catalogue Of Somatic Mutations In Cancer.
John G Tate, Sally Bamford, Harry C Jubb, Zbyslaw Sondka, David M Beare, Nidhi Bindal, Harry Boutselakis, Charlotte G Cole, Celestino Creatore, Elisabeth Dawson,[...]. Nucleic Acids Res 2019
891
4

The evolutionary history of 2,658 cancers.
Moritz Gerstung, Clemency Jolly, Ignaty Leshchiner, Stefan C Dentro, Santiago Gonzalez, Daniel Rosebrock, Thomas J Mitchell, Yulia Rubanova, Pavana Anur, Kaixian Yu,[...]. Nature 2020
167
4

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
Daniel J Brat, Kenneth Aldape, Howard Colman, Eric C Holland, David N Louis, Robert B Jenkins, B K Kleinschmidt-DeMasters, Arie Perry, Guido Reifenberger, Roger Stupp,[...]. Acta Neuropathol 2018
244
4

Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Akihiro Fujimoto, Mayuko Furuta, Yasushi Totoki, Tatsuhiko Tsunoda, Mamoru Kato, Yuichi Shiraishi, Hiroko Tanaka, Hiroaki Taniguchi, Yoshiiku Kawakami, Masaki Ueno,[...]. Nat Genet 2016
333
3

TERT promoter mutations and monoallelic activation of TERT in cancer.
F W Huang, C M Bielski, M L Rinne, W C Hahn, W R Sellers, F Stegmeier, L A Garraway, G V Kryukov. Oncogenesis 2015
37
8

Same-day genomic and epigenomic diagnosis of brain tumors using real-time nanopore sequencing.
Philipp Euskirchen, Franck Bielle, Karim Labreche, Wigard P Kloosterman, Shai Rosenberg, Mailys Daniau, Charlotte Schmitt, Julien Masliah-Planchon, Franck Bourdeaut, Caroline Dehais,[...]. Acta Neuropathol 2017
51
5

Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.
Isaia Barbieri, Konstantinos Tzelepis, Luca Pandolfini, Junwei Shi, Gonzalo Millán-Zambrano, Samuel C Robson, Demetrios Aspris, Valentina Migliori, Andrew J Bannister, Namshik Han,[...]. Nature 2017
345
3

Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications.
Xiaoyu Chen, Ole Schulz-Trieglaff, Richard Shaw, Bret Barnes, Felix Schlesinger, Morten Källberg, Anthony J Cox, Semyon Kruglyak, Christopher T Saunders. Bioinformatics 2016
451
3

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer.
Ricardo Leão, Donghyun Lee, Arnaldo Figueiredo, Thomas Hermanns, Peter Wild, Martin Komosa, Irene Lau, Mathew Mistry, Nuno Miguel Nunes, Aryeh J Price,[...]. Int J Cancer 2019
19
15

A highly selective telomerase inhibitor limiting human cancer cell proliferation.
K Damm, U Hemmann, P Garin-Chesa, N Hauel, I Kauffmann, H Priepke, C Niestroj, C Daiber, B Enenkel, B Guilliard,[...]. EMBO J 2001
308
3

Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.
Michele Ceccarelli, Floris P Barthel, Tathiane M Malta, Thais S Sabedot, Sofie R Salama, Bradley A Murray, Olena Morozova, Yulia Newton, Amie Radenbaugh, Stefano M Pagnotta,[...]. Cell 2016
891
3

Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532.
Christopher Bryan, Cory Rice, Hunter Hoffman, Michael Harkisheimer, Melanie Sweeney, Emmanuel Skordalakes. Structure 2015
37
8

Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types.
A Kilian, D D Bowtell, H E Abud, G R Hime, D J Venter, P K Keese, E L Duncan, R R Reddel, R A Jefferson. Hum Mol Genet 1997
496
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.